Records containing: Non ST Segment Elevation Myocardial Infarction
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-14Multicenter Registry for Instantaneous Wave-Free Ratio (iFR)-Guided Percutaneous Coronary Intervention in Routine Clinical Practice
-
CLINICAL_TRIALS study record update · 2024-10-30Treatment of ACuTe Coronary Syndromes With Low-dose colchICine (TACTIC): a Randomised, Double-blinded, Placebo-controlled, Multicentric Trial
-
CLINICAL_TRIALS study record update · 2023-10-06Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
-
CLINICAL_TRIALS study record update · 2023-06-06Distal Radial Artery Access in Comparison to Forearm Radial Artery Access for Cardiac Catheterization, a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-11-10Does Optical Coherence Tomography Optimise Results of Stenting of the Left Main Stem
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-05-05OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)
-
CLINICAL_TRIALS study record update · 2019-03-07One-hour Diagnostic Algorithm for Non-ST Elevation Myocardial Infarction Based on Determination of Fatty-acid-binding Protein Concentration
-
CLINICAL_TRIALS study record update · 2019-03-05EKG Criteria and Identification of Acute Coronary Occlusion
-
CLINICAL_TRIALS study record update · 2015-06-18A Multicenter, Randomized, Open-label, Non-inferiority Phase III Study, Between Low-Molecular Weight Heparins, Versa® (Enoxaparin - Eurofarma) and Clexane® (Enoxaparin - Sanofi-Aventis), in Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation.
-
CLINICAL_TRIALS study record update · 2015-06-16ClinicalTrials.gov study NCT02070679